InvestorsHub Logo
icon url

ralphey

01/28/22 2:00 PM

#367942 RE: couldbebetter #367940

Yes Pfizer could an intelligent 8th grader could as well - doesn't say much for AMRN's management - glad they are getting shook down -
icon url

Whalatane

01/28/22 2:15 PM

#367947 RE: couldbebetter #367940

CBB. PFE has little interest IMHO in AMRN. Their focus is on their Covid vaccine and the likely additional booster we'll need this year . They are making plenty of $ with that and have no need for a Co with no patent protection in the US
Your other picks ...Roche, Novo Nordisk , Merck . Roche ...no significant presence in the EU CV market
Novo Nordisk and Merck ...some presence in Diabetes and Heart failure

None of these Co's have the EU exposure in CV drugs ...as NVS does with their marketing programs for Entresto and Inclisiran

Your PFE acquisition dream isn't going anywhere IMHO and since U insist on repeating the same posts over and over again I think I'll skip reading them for awhile

Kiwi